Literature DB >> 11820219

Serial plasma concentrations of atrial natriuretic peptide, plasma renin activity, aldosterone, and antidiuretic hormone in neonates on extracorporeal membrane oxygenation.

Ben A Semmekrot1, Gerard J Pesman, Paul N Span, C G J Sweep, Arno F J van Heijst, Leo A H Monnens, Margot van de Bor, Ronald B Tanke, Frans H J M van der Staak.   

Abstract

To obtain information on water and salt regulating hormones and volume homeostasis during neonatal extracorporeal membrane oxygenation (ECMO), serial determinations of atrial natriuretic peptide (ANP), plasma renin activity (PRA), aldosterone (Aldo), antidiuretic hormone (ADH), colloid-osmotic pressure (COP), osmolality (Osmol), and central venous pressure (CVP) before, during, and after neonatal ECMO in 10 neonates with meconium aspiration syndrome (MAS) were carried out. Mean gestational ages and birth weights were 41(+3) weeks (39(+6) - 42(+4)) and 4,063 gm (3,500-4700), respectively; mean age at start and duration of ECMO 29.3 (14-69) and 152.6 hr (92-267), respectively. Plasma ANP (mean +/- SD) was 67.8+/-69.1 pmol/L before, decreased to 33.3+/-22.1 (not significant) pmol/L during, and significantly increased to 274.6+/-131.8 pmol/L after ECMO (p < 0.05). ANP correlated positively with CVP (r = 0.63; p < 0.001). Pre-ECMO PRA, Aldo, and ADH were comparable to those described earlier in normal neonates, decreased during (p < 0.001 for Aldo; p < 0.05 for PRA and ADH) and either remained elevated (PRA, p < 0.001; Aldo, p < 0.05) or decreased (ADH) after ECMO. COP and Osmol remained unchanged. Neonatal ECMO for MAS is characterized by circulatory and osmotic equilibrium. It is suggested that circulating volume contracts during and expands after neonatal ECMO for MAS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11820219     DOI: 10.1097/00002480-200201000-00007

Source DB:  PubMed          Journal:  ASAIO J        ISSN: 1058-2916            Impact factor:   2.872


  6 in total

1.  Extracorporeal Membrane Oxygenation and the Kidney.

Authors:  Gianluca Villa; Nevin Katz; Claudio Ronco
Journal:  Cardiorenal Med       Date:  2015-10-17       Impact factor: 2.041

2.  Critically low hormone and catecholamine concentrations in the primed extracorporeal life support circuit.

Authors:  Michael S D Agus; Tom Jaksic
Journal:  ASAIO J       Date:  2004 Jan-Feb       Impact factor: 2.872

3.  Initial experience with conivaptan use in critically ill infants with cardiac disease.

Authors:  Ryan C Jones; Surender Rajasekaran; Mark Rayburn; Joseph D Tobias; Robert M Kelsey; Glenn T Wetzel; Antonio G Cabrera
Journal:  J Pediatr Pharmacol Ther       Date:  2012-01

4.  Acute Kidney Injury in Pediatric Patients on Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-analysis.

Authors:  Panupong Hansrivijit; Ploypin Lertjitbanjong; Charat Thongprayoon; Wisit Cheungpasitporn; Narothama Reddy Aeddula; Sohail Abdul Salim; Api Chewcharat; Kanramon Watthanasuntorn; Narat Srivali; Michael A Mao; Patompong Ungprasert; Karn Wijarnpreecha; Wisit Kaewput; Tarun Bathini
Journal:  Medicines (Basel)       Date:  2019-11-01

Review 5.  Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock.

Authors:  Adamantios Tsangaris; Tamas Alexy; Rajat Kalra; Marinos Kosmopoulos; Andrea Elliott; Jason A Bartos; Demetris Yannopoulos
Journal:  Front Cardiovasc Med       Date:  2021-07-07

6.  Incidence of Acute Kidney Injury Is Lower in High-Risk Patients Undergoing Percutaneous Coronary Intervention Supported with Impella Compared to ECMO.

Authors:  Julian Schweitzer; Patrick Horn; Fabian Voss; Milena Kivel; Georg Wolff; Christian Jung; Tobias Zeus; Malte Kelm; Ralf Westenfeld
Journal:  J Cardiovasc Transl Res       Date:  2021-07-29       Impact factor: 3.216

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.